+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Electroporation Instruments Market 2021-2025

  • ID: 4894503
  • Report
  • May 2021
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • BEX Co. Ltd.
  • Bio Rad Laboratories Inc
  • Celetrix LLC
  • Eppendorf AG
  • Harvard Bioscience Inc.
  • Lonza Group Ltd.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the electroporation instruments market and it is poised to grow by $87.59 mn during 2021-2025, progressing at a CAGR of almost 8% during the forecast period. The report on electroporation instruments market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising demand for monoclonal antibodies and emerging economies offering growth opportunities. In addition, rising demand for monoclonal antibodies is anticipated to boost the growth of the market as well.

The electroporation instruments market analysis include end-user segments and geographic landscape.

The electroporation instruments market is segmented as below:

By End-user
  • Pharma and biotech companies
  • Academic and research institutes
  • CROs

By Geography
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing incidence and prevalence of cancer as one of the prime reasons driving the electroporation instruments market growth during the next few years.

The report on electroporation instruments market covers the following areas:
  • Electroporation instruments market sizing
  • Electroporation instruments market forecast
  • Electroporation instruments market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading electroporation instruments market vendors that include BEX Co. Ltd., Bio Rad Laboratories, Inc, Celetrix LLC, Eppendorf AG, Harvard Bioscience Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC., and Thermo Fisher Scientific Inc. Also, the electroporation instruments market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BEX Co. Ltd.
  • Bio Rad Laboratories Inc
  • Celetrix LLC
  • Eppendorf AG
  • Harvard Bioscience Inc.
  • Lonza Group Ltd.

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user
  • Market segments
  • Comparison by End-user
  • Pharma and biotech companies - Market size and forecast 2020-2025
  • Academic and research institutes - Market size and forecast 2020-2025
  • CROs - Market size and forecast 2020-2025
  • Market opportunity by End-user

Customer landscape
  • Overview

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Landscape disruption
  • Competitive scenario

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • BEX Co. Ltd.
  • Celetrix LLC
  • Eppendorf AG
  • Harvard Bioscience Inc.
  • Lonza Group Ltd.
  • MaxCyte Inc.
  • Merck KGaA
  • Mirus Bio LLC.
  • Thermo Fisher Scientific Inc.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • End user - Market share 2020-2025 (%)
  • Comparison by End user
  • Pharma and biotech companies - Market size and forecast 2020-2025 ($ million)
  • Pharma and biotech companies - Year-over-year growth 2020-2025 (%)
  • Academic and research institutes - Market size and forecast 2020-2025 ($ million)
  • Academic and research institutes - Year-over-year growth 2020-2025 (%)
  • CROs - Market size and forecast 2020-2025 ($ million)
  • CROs - Year-over-year growth 2020-2025 (%)
  • Market opportunity by End user
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • BEX Co. Ltd. - Overview
  • BEX Co. Ltd. - Product and service
  • BEX Co. Ltd. - Key offerings
  • BEX Co. Ltd. - Key customers
  • BEX Co. Ltd. - Segment focus
  • Bio Rad Laboratories, Inc - Overview
  • Bio Rad Laboratories, Inc - Business segments
  • Bio Rad Laboratories, Inc - Key offerings
  • Bio Rad Laboratories, Inc - Key customers
  • Bio Rad Laboratories, Inc - Segment focus
  • Celetrix LLC - Overview
  • Celetrix LLC - Product and service
  • Celetrix LLC - Key offerings
  • Celetrix LLC - Key customers
  • Celetrix LLC - Segment focus
  • Eppendorf AG - Overview
  • Eppendorf AG - Business segments
  • Eppendorf AG - Key offerings
  • Eppendorf AG - Key customers
  • Eppendorf AG - Segment focus
  • Harvard Bioscience Inc. - Overview
  • Harvard Bioscience Inc. - Business segments
  • Harvard Bioscience Inc. - Key offerings
  • Harvard Bioscience Inc. - Key customers
  • Harvard Bioscience Inc. - Segment focus
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Key customers
  • Lonza Group Ltd. - Segment focus
  • MaxCyte Inc. - Overview
  • MaxCyte Inc. - Business segments
  • MaxCyte Inc. - Key offerings
  • MaxCyte Inc. - Key customers
  • MaxCyte Inc. - Segment focus
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key offerings
  • Merck KGaA - Key customers
  • Merck KGaA - Segment focus
  • Mirus Bio LLC. - Overview
  • Mirus Bio LLC. - Product and service
  • Mirus Bio LLC. - Key offerings
  • Mirus Bio LLC. - Key customers
  • Mirus Bio LLC. - Segment focus
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Key customers
  • Thermo Fisher Scientific Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BEX Co. Ltd.
  • Bio Rad Laboratories Inc
  • Celetrix LLC
  • Eppendorf AG
  • Harvard Bioscience Inc.
  • Lonza Group Ltd.
The publisher recognizes the following companies as the key players in the global electroporation instruments market: BEX Co. Ltd., Bio Rad Laboratories, Inc, Celetrix LLC, Eppendorf AG, Harvard Bioscience Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the growing incidence and prevalence of cancer.'

According to the report, one of the major drivers for this market is the rising demand for monoclonal antibodies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • BEX Co. Ltd.
  • Bio Rad Laboratories Inc
  • Celetrix LLC
  • Eppendorf AG
  • Harvard Bioscience Inc.
  • Lonza Group Ltd.
  • MaxCyte Inc.
  • Merck KGaA
  • Mirus Bio LLC.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown